Briacell Therapeutics Corp. Common Shares (BCTX) stock analysis and AI prediction
The company facts of Briacell Therapeutics Corp. Common Shares, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Briacell Therapeutics Corp. Common Shares
BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab in a pivotal Phase 3 study in metastatic breast cancer. The Company's operations focus on the research and development of its immunotherapy product candidates and related supporting activities.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $30.7 million
- Size
- Micro cap
- Employees
- 31
- Headquarters
- WEST VANCOUVER, A1
- Listed since
- Sept. 5, 2023
- Website
- briacell.com
More Healthcare stocks
Other micro cap stocks
Keep going
BCTX questions
What is the AI prediction for BCTX stock?
Each market day our model rates Briacell Therapeutics Corp. Common Shares (BCTX) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the BCTX prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for BCTX?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see BCTX options?
The BCTX options page opens its calls and puts, with price, volume, implied volatility and the Greeks.